These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6850526)

  • 1. Clinical trials and the community physician.
    Levine AS
    Cancer; 1983 Jun; 51(12 Suppl):2498-502. PubMed ID: 6850526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials. A family physician's perspective.
    Long DG
    Cancer; 1991 Mar; 67(6 Suppl):1798-9. PubMed ID: 2001581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials for cancer patients. The community practicing physician's perspective.
    Fleming ID
    Cancer; 1990 May; 65(10 Suppl):2388-90. PubMed ID: 2334879
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer clinical trials in the USA: patient eligibility, generalizability of results and technology transfer.
    Begg CB
    Bull Cancer; 1987; 74(2):197-203. PubMed ID: 3607303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group.
    Begg CB; Carbone PP; Elson PJ; Zelen M
    N Engl J Med; 1982 May; 306(18):1076-80. PubMed ID: 7070403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the community oncologist.
    Yates JW
    Urology; 1984 Apr; 23(4 Suppl):149-52. PubMed ID: 6369717
    [No Abstract]   [Full Text] [Related]  

  • 7. Composite randomization designs for clinical trials.
    Simon R
    Biometrics; 1981 Dec; 37(4):723-31. PubMed ID: 7337792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On design considerations and randomization-based inference for community intervention trials.
    Gail MH; Mark SD; Carroll RJ; Green SB; Pee D
    Stat Med; 1996 Jun; 15(11):1069-92. PubMed ID: 8804140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpreting physician participation in randomized clinical trials: the Physician Orientation Profile.
    Taylor KM; Kelner M
    J Health Soc Behav; 1987 Dec; 28(4):389-400. PubMed ID: 3429808
    [No Abstract]   [Full Text] [Related]  

  • 11. Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log.
    Hunter CP; Frelick RW; Feldman AR; Bavier AR; Dunlap WH; Ford L; Henson D; Macfarlane D; Smart CR; Yancik R
    Cancer Treat Rep; 1987 Jun; 71(6):559-65. PubMed ID: 3581095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Randomization for controlled therapeutic trials].
    Schemper M
    Wien Klin Wochenschr; 1982 Nov; 94(22):604-9. PubMed ID: 7164464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperative groups and community hospitals. Measurement of impact in the community hospitals.
    Begg CB; Zelen M; Carbone PP; McFadden ET; Brodovsky H; Engstrom P; Hatfield A; Ingle J; Schwartz B; Stolbach L
    Cancer; 1983 Nov; 52(9):1760-7. PubMed ID: 6616426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection bias in clinical trials.
    Antman K; Amato D; Wood W; Carson J; Suit H; Proppe K; Carey R; Greenberger J; Wilson R; Frei E
    J Clin Oncol; 1985 Aug; 3(8):1142-7. PubMed ID: 4020412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assuring access to state-of-the-art care for U.S. minority populations: the first 2 years of the Minority-Based Community Clinical Oncology Program.
    Kaluzny A; Brawley O; Garson-Angert D; Shaw J; Godley P; Warnecke R; Ford L
    J Natl Cancer Inst; 1993 Dec; 85(23):1945-50. PubMed ID: 8230286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient accrual to clinical trials.
    Friedman MA
    Cancer Treat Rep; 1987 Jun; 71(6):557-8. PubMed ID: 3581094
    [No Abstract]   [Full Text] [Related]  

  • 18. Cancer clinical trials in the community setting: a 20 year retrospective.
    Avent RA; Dillman RO
    Cancer Biother; 1995; 10(2):95-113. PubMed ID: 7663578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationship of cancer control and clinical research in the community.
    Enck RE
    CA Cancer J Clin; 1984; 34(6):340-4. PubMed ID: 6437625
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.